m6A has been reported its potential connections with IBD, METTL3 and METTL14 deficiency in immune cell induce colitis; m6A eraser FTO protects IBD patients from adverse reactions after thiopurine treatment (Xu et al., 2021). Here, FTO is linked to colitis.